Humana Inc (NYSE:HUM) CEO Bruce D. Broussard sold 14,075 shares of the firm’s stock in a transaction on Monday, February 26th. The shares were sold at an average price of $274.32, for a total transaction of $3,861,054.00. Following the sale, the chief executive officer now owns 113,896 shares in the company, valued at approximately $31,243,950.72. The transaction was disclosed in a document filed with the SEC, which is accessible through this link.
Humana Inc (NYSE:HUM) opened at $276.92 on Wednesday. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.48. Humana Inc has a twelve month low of $203.48 and a twelve month high of $293.35. The company has a market cap of $37,805.36, a price-to-earnings ratio of 16.60, a P/E/G ratio of 1.48 and a beta of 0.93.
Humana (NYSE:HUM) last released its earnings results on Wednesday, February 7th. The insurance provider reported $2.06 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.00 by $0.06. Humana had a net margin of 4.55% and a return on equity of 16.13%. The company had revenue of $13.19 billion for the quarter, compared to analyst estimates of $13.14 billion. During the same quarter last year, the firm earned $2.34 EPS. The firm’s quarterly revenue was up 2.4% compared to the same quarter last year. research analysts forecast that Humana Inc will post 13.86 earnings per share for the current year.
Humana announced that its Board of Directors has initiated a share repurchase program on Thursday, December 14th that permits the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization permits the insurance provider to buy shares of its stock through open market purchases. Shares repurchase programs are often an indication that the company’s leadership believes its shares are undervalued.
Several research firms have recently weighed in on HUM. BMO Capital Markets raised their price objective on shares of Humana from $290.00 to $300.00 and gave the company an “outperform” rating in a research report on Friday, November 10th. Royal Bank of Canada restated a “sector perform” rating and set a $242.00 price objective (down previously from $245.00) on shares of Humana in a research report on Thursday, November 9th. JPMorgan Chase & Co. raised their price objective on shares of Humana from $253.00 to $271.00 and gave the company a “neutral” rating in a research report on Monday, February 12th. Zacks Investment Research cut shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 19th. Finally, Morgan Stanley lowered their price objective on shares of Humana from $276.00 to $270.00 and set an “overweight” rating on the stock in a research report on Thursday, November 9th. Seven investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Humana currently has a consensus rating of “Buy” and an average price target of $270.47.
A number of institutional investors have recently made changes to their positions in the business. Janus Henderson Group PLC grew its holdings in Humana by 74.1% in the 3rd quarter. Janus Henderson Group PLC now owns 2,729,248 shares of the insurance provider’s stock worth $664,921,000 after acquiring an additional 1,161,661 shares during the last quarter. Wells Fargo & Company MN grew its holdings in Humana by 11.4% in the 4th quarter. Wells Fargo & Company MN now owns 1,842,029 shares of the insurance provider’s stock worth $456,951,000 after acquiring an additional 188,711 shares during the last quarter. Geode Capital Management LLC grew its holdings in Humana by 1.9% in the 4th quarter. Geode Capital Management LLC now owns 1,522,654 shares of the insurance provider’s stock worth $376,937,000 after acquiring an additional 28,147 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in Humana by 10.8% in the 3rd quarter. Ameriprise Financial Inc. now owns 1,465,119 shares of the insurance provider’s stock worth $356,960,000 after acquiring an additional 142,706 shares during the last quarter. Finally, Acadian Asset Management LLC grew its holdings in Humana by 3.0% in the 4th quarter. Acadian Asset Management LLC now owns 1,043,303 shares of the insurance provider’s stock worth $258,809,000 after acquiring an additional 30,812 shares during the last quarter. 97.68% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION WARNING: “Humana Inc (HUM) CEO Sells $3,861,054.00 in Stock” was posted by Ticker Report and is owned by of Ticker Report. If you are reading this piece on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3227940/humana-inc-hum-ceo-sells-3861054-00-in-stock.html.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.